Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: A systematic review

Orphanet Journal of Rare Diseases

Volumn 9, Issue 1, 2014, Pages

  Bonnot, Olivier ^a,f   Klünemann, Hans Hermann ^b   Sedel, Frederic ^c   Tordjman, Sylvie ^d   Cohen, David ^c   Walterfang, Mark ^e,g  

^a Hopital Mere Enfant CHU de Nantes   (France)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITÉ DE RENNES 1   (France)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f GDR3557 Institut de Psychiatrie   (France)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Atypical psychosis; Inborn errors of metabolism; Organic psychosis; Schizophrenia like symptoms

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARGINASE; ARGININOSUCCINATE LYASE; ARGININOSUCCINATE SYNTHASE; BETAINE; CARBAMATE KINASE; CARBAMAZEPINE; CARNITINE; CLOZAPINE; CORTICOSTEROID; CYANOCOBALAMIN; CYSTATHIONINE; CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; FOLINIC ACID; GLUTAMATE ACETYLTRANSFERASE; HOMOCYSTEINE; HYDROXOCOBALAMIN; METHIONINE; METHYLTETRAHYDROFOLATE REDUCTASE; MIGLUSTAT; OLANZAPINE; ORNITHINE CARBAMOYLTRANSFERASE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE; QUETIAPINE; RISPERIDONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID;

ACADEMIC ACHIEVEMENT; ACUTE INTERMITTENT PORPHYRIA; ADULT DISEASE; AGGRESSION; AMINO ACID BLOOD LEVEL; APNEA; ATAXIC GAIT; AUDITORY HALLUCINATION; BABINSKI REFLEX; BIPOLAR DISORDER; CARBON METABOLISM; CEREBROTENDINOUS XANTHOMATOSIS; CHELATION THERAPY; CLINICAL FEATURE; COGNITIVE DEFECT; COMA; COMPUTER ASSISTED TOMOGRAPHY; CONDUCT DISORDER; CONGENITAL ERYTHROPOIETIC PORPHYRIA; CONVULSION; CYANOCOBALAMIN DEFICIENCY; DELUSION; DEPRESSION; DISEASE COURSE; DYSARTHRIA; ECTOPIA LENTIS; ELECTROCONVULSIVE THERAPY; ENZYME ACTIVITY; ENZYME DEFICIENCY; EXECUTIVE FUNCTION; FUNNEL CHEST; GENE MUTATION; HEPATIC PORPHYRIA; HIGH MYOPIA; HOSPITAL ADMISSION; HUMAN; HYPERAMMONEMIA; INTELLIGENCE QUOTIENT; KYPHOSCOLIOSIS; LETHARGY; LIVEDO RETICULARIS; MAJOR DEPRESSION; MEGALOBLASTIC ANEMIA; MENTAL DEFICIENCY; MENTAL DETERIORATION; MENTAL HEALTH; METABOLIC DISORDER; MICROCEPHALY; MUSCLE TONE; NAUSEA AND VOMITING; NIEMANN PICK DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; OSTEOPOROSIS; PARAPLEGIA; PERSONALITY DISORDER; PHOTOSENSITIVITY; PROTEIN RESTRICTION; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; TALL STATURE; THOUGHT DISORDER; THROMBOEMBOLISM; UREA CYCLE; UREA CYCLE DISORDER; VALGUS KNEE; VITAMIN BLOOD LEVEL; WILSON DISEASE;

HUMANS; METABOLIC DISEASES; PSYCHOTIC DISORDERS;

EID: 84902135297     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-9-65     Document Type: Review

References (151)

1. Schizophrenia and schizophrenia-like psychosis. Price G, Ron MA, Neurology and Clinical Neuroscience St Louis: Elsevier-Mosby, Schapira AHV, 1 2003 223 233
2. Schizophrenia-like psychoses associated with organic cerebral disorders: a review. Davison K, Bagley CR, Psychiatr Dev 1983 1 1 1 33
3. The occurrence of organic disease of possible or probable aetiological significance in a population of 268 cases of first episode schizophrenia. Johnstone EC, Macmillan JF, Crow TJ, Psychol Med 1987 17 2 371 379
4. The differential diagnosis of childhood and young adult onset disorders that include psychosis. Lauterbach MD, Stanislawski-Zygaj AL, Benjamin S, J Neuropsychiatry Clin Neurosci 2008 20 4 409 418
5. Neurometabolic disorders. Saudubray JM, J Inherit Metab Dis 2009 32 5 595 596
6. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Applegarth DA, Toone JR, Lowry RB, Pediatrics 2000 105 1 10
7. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. Sedel F, Baumann N, Turpin JC, Lyon-Caen O, Saudubray JM, Cohen D, J Inherit Metab Dis 2007 30 5 631 641
8. Psychiatric considerations of certain neurological diseases treated neurosurgically. Wilson WP, Nashold BS Jr, Int Psychiatry Clin 1967 4 2 189 204
9. [Psychiatric and cognitive signs associated with inborn errors of metabolism]. Bonnot O, Cohen D, Rev Neurol 2011 167 12 881 885
10. Psychiatric symptoms of inherited metabolic disease. Estrov Y, Scaglia F, Bodamer OA, J Inherit Metab Dis 2000 23 1 2 6
11. Inborn errors of metabolism: a clinical overview. Sao Paulo medical journal =. Martins AM, Rev Paul Med 1999 117 6 251 265
12. Metabolic disorders presenting with behavioral symptoms in the school-aged child. Trifiletti RR, Packard AM, Child Adolesc Psychiatr Clin N Am 1999 8 4 791 806
13. KEGG, Reference Metabolic Pathways 2013 [cited 2014 January]; Available from: http://www.genome.jp/kegg/pathway.html
14. Yap S, 2007 [cited January, 2014]; Available from: http://www.orpha.net/ consor/cgi-bin/OC-Exp.php?Lng=FR&Expert=394
15. Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness. Abbott MH, Folstein SE, Abbey H, Pyeritz RE, Am J Med Genet 1987 26 4 959 969
16. Homocystinuria and psychiatric disorder: a case report. Li SC, Stewart PM, Pathology 1999 31 3 221 224
17. Inherited disorders in the conversion of methionine to homocysteine. Baric I, J Inherit Metab Dis 2009 32 4 459 471
18. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Mattson MP, Shea TB, Trends Neurosci 2003 26 3 137 146
19. Neuropsychiatric disturbances in presumed late-onset cobalamin C disease. Roze E, Gervais D, Demeret S, Ogier de Baulny H, Zittoun J, Benoist JF, Said G, Pierrot-Deseilligny C, Bolgert F, Arch Neurol 2003 60 10 1457 1462
20. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Gilbody S, Lewis S, Lightfoot T, Am J Epidemiol 2007 165 1 1 13
21. Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants. Ellingrod VL, Miller DD, Taylor SF, Moline J, Holman T, Kerr J, Schizophr Res 2008 98 1-3 47 54
22. The role of one-carbon metabolism in schizophrenia and depression. Frankenburg FR, Harv Rev Psychiatry 2007 15 4 146 160
23. Gene-nutrient interactions in one-carbon metabolism. Friso S, Choi SW, Curr Drug Metab 2005 6 1 37 46
24. Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics. Sharma RP, Schizophr Res 2005 72 2-3 79 90
25. Schizophrenia and single-carbon metabolism. Regland B, Prog Neuro-Psychopharmacol Biol Psychiatry 2005 29 7 1124 1132
26. The significance of homocysteine levels in schizophrenia. O'Donnell C, Stephens T, Am J Psychiatry 2005 162 7 1387 1388 author reply 1388-1389
27. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M, Mol Psychiatry 2006 11 2 143 149
28. Suggested guidelines for the diagnosis and management of urea cycle disorders. Haberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, Karall D, Martinelli D, Crespo PS, Santer R, Servais A, Valayannopoulos V, Lindner M, Rubio V, Dionisi-Vici C, Orphanet J Rare Dis 2012 7 32
29. Nutritional management of patients with urea cycle disorders. Singh RH, J Inherit Metab Dis 2007 30 6 880 887
30. Urea cycle disorders: clinical presentation outside the newborn period. Smith W, Kishnani PS, Lee B, Singh RH, Rhead WJ, Sniderman King L, Smith M, Summar M, Crit Care Clin 2005 21 4 Suppl 9 17
31. Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus. A cause of postpartum coma. Arn PH, Hauser ER, Thomas GH, Herman G, Hess D, Brusilow SW, N Engl J Med 1990 322 23 1652 1655
32. Postpartum "psychosis" in mild argininosuccinate synthetase deficiency. Enns GM, O'Brien WE, Kobayashi K, Shinzawa H, Pellegrino JE, Obstet Gynecol 2005 105 5 Pt 2 1244 1246
33. Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Bachmann C, Eur J Pediatr 2003 162 6 410 416
34. Intellectual, adaptive, and behavioral functioning in children with urea cycle disorders. Krivitzky L, Babikian T, Lee HS, Thomas NH, Burk-Paull KL, Batshaw ML, Pediatr Res 2009 66 1 96 101
35. Late diagnosis of ornithine transcarbamylase defect in three related female patients: polymorphic presentations. Legras A, Labarthe F, Maillot F, Garrigue MA, Kouatchet A, Ogier de Baulny H, Crit Care Med 2002 30 1 241 244
36. Vomiting, ataxia, and altered mental status in an adolescent: late-onset ornithine transcarbamylase deficiency. Myers JH, Shook JE, Am J Emerg Med 1996 14 6 553 557
37. Acute hyperammonemic encephalopathy in adult onset ornithine transcarbamylase deficiency. Panlaqui OM, Tran K, Johns A, McGill J, White H, Intensive Care Med 2008 34 10 1922 1924
38. Fatal ammonia toxicity in an adult due to an undiagnosed urea cycle defect: under-recognition of ornithine transcarbamylase deficiency. Thurlow VR, Asafu-Adjaye M, Agalou S, Rahman Y, Ann Clin Biochem 2010 47 Pt 3 279 281
39. Orphanet, Prevalence of rare diseases by alphabetical list 2013 [cited January, 2014]; Available from: http://www.orpha.net/orphacom/cahiers/docs/GB/ Prevalence-of-rare-diseases-by-alphabetical-list.pdf
40. Psychiatric aspects of acute porphyria. Cashman MD, Lancet 1961 1 7168 115 116
41. High prevalence of intermittent acute porphyria in a psychiatric patient population. Tishler PV, Woodward B, O'Connor J, Holbrook DA, Seidman LJ, Hallett M, Knighton DJ, Am J Psychiatry 1985 142 12 1430 1436
42. Acute intermittent porphyria in a children's psychiatric hospital. Boon FF, Ellis C, J Am Acad Child Adolesc Psychiatry 1989 28 4 606 609
43. Varied psychiatric manifestations of acute intermittent porphyria. Santosh PJ, Malhotra S, Biol Psychiatry 1994 36 11 744 747
44. Acute intermittent porphyria: a study of 50 cases. Goldberg A, Q J Med 1959 28 110 183 209
45. Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Stein JA, Tschudy DP, Medicine 1970 49 1 1 16
46. Neurologic manifestations of acute porphyria. Bonkowsky HL, Schady W, Semin Liver Dis 1982 2 2 108 124
47. Psychiatric manifestations of hereditary coproporphyria in a child. Mandoki MW, Sumner GS, J Nerv Ment Dis 1994 182 2 117 118
48. Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood. Brodie MJ, Thompson GG, Moore MR, Beattie AD, Goldberg A, Q J Med 1977 46 182 229 241
49. The little imitator-porphyria: a neuropsychiatric disorder. Crimlisk HL, J Neurol Neurosurg Psychiatry 1997 62 4 319 328
50. Hereditary coproporphyria in Germany: clinical-biochemical studies in 53 patients. Kuhnel A, Gross U, Doss MO, Clin Biochem 2000 33 6 465 473
51. A molecular, enzymatic and clinical study in a family with hereditary coproporphyria. Gross U, Puy H, Meissauer U, Lamoril J, Deybach JC, Doss M, Nordmann Y, Doss MO, J Inherit Metab Dis 2002 25 4 279 286
52. Wilson's disease. Pfeffer RF, Semin Neurol 2007 27 2 123 132
53. Wilson's disease: an analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents. Williams J, Walshe J, Brain 1981 104 735 752
54. Initial and follow-up brain MRI findings and correlation with the clinical course in Wilson's disease. Roh JK, Lee TG, Wie BA, Lee SB, Park SH, Chang KH, Neurology 1994 44 6 1064 1068
55. Wilson's disease studied with FDG and positron emission tomography. Hawkins RA, Mazziotta JC, Phelps ME, Neurology 1987 37 11 1707 1711
56. Aggregation of blood platelets by adrenaline and its uptake. Barthel W, Markwardt F, Biochem Pharmacol 1975 24 20 1903 1904
57. The neuropsychiatry of Wilson's disease: a review. Dening TR, Int J Psychiatry Med 1991 21 2 135 148
58. [Psychiatric manifestations in Wilson's disease]. Schwartz M, Fuchs S, Polak H, Sharf B, Harefuah 1993 124 2 75 77 120
59. Neuropsychological aspects of Wilson's disease. Rathbun JK, Int J Neurosci 1996 85 3-4 221 229
60. Wilson's disease. Psychiatric symptoms in 195 cases. Dening TR, Berrios GE, Arch Gen Psychiatry 1989 46 12 1126 1134
61. Psychiatric aspects of Wilson's disease. Dening TR, Br J Psychiatry 1985 147 677 682
62. Pharmacological properties of new neuroleptic compounds. Coscia L, Causa P, Giuliani E, Nunziata A, Arzneimittelforschung 1975 25 9 1436 1442
63. Psychiatric and behavioral abnormalities in Wilson's disease. Akil M, Brewer GJ, Adv Neurol 1995 65 171 178
64. The psychiatric presentations of Wilson's disease. Akil M, Schwartz JA, Dutchak D, Yuzbasiyan-Gurkan V, Brewer GJ, J Neuropsychiatry Clin Neurosci 1991 3 4 377 382
65. Wilson's disease: a longitudinal study of psychiatric symptoms. Dening TR, Berrios GE, Biol Psychiatry 1990 28 3 255 265
66. Psychopathology in patients with Wilson's disease. Medalia A, Scheinberg IH, Am J Psychiatry 1989 146 5 662 664
67. Dominant psychiatric manifestations in Wilson's disease: a diagnostic and therapeutic challenge! Srinivas K, Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Janardhana Reddy YC, Khanna S, J Neurol Sci 2008 266 1-2 104 108
68. Effects of 5,6-dihydroxytryptamine on tyrosine-hydroxylase activity in central catecholaminergic neurons of the rat. Renaud B, Buda M, Lewis BD, Pujol JF, Biochem Pharmacol 1975 24 18 1739 1742
69. Wilson disease: description of 282 patients evaluated over 3 decades. Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR, Medicine 2007 86 2 112 121
70. [Wilson's disease associated with olfactory paranoid syndrome and idiopathic thrombocytopenic purpura]. Sagawa M, Takao M, Nogawa S, Mizuno M, Murata M, Amano T, Koto A, No to shinkei = Brain and nerve 2003 55 10 899 902
71. Wilson's disease asociated with delusional disorder. Wichowicz H, Cubala W, Slawek J, Psychiatry Clin Neurosci 2006 60 758 760
72. Delusional disorder and alcohol abuse in a patient with Wilson's disease. Spyridi S, Diakogiannis I, Michaelides M, Sokolaki S, Iacovides A, Kaprinis G, Gen Hosp Psychiatry 2008 30 6 585 586
73. Wilson's disease in psychiatric patients. Stiller P, Kassubek J, Schonfeldt-Leucona C, Connemann B, Psychiatry Clin Neurosci 2008 56 649
74. Neuropsychological impairment in Wilson's disease. Medalia A, Isaacs-Glaberman K, Scheinberg IH, Arch Neurol 1988 45 5 502 504
75. Verbal recall and recognition abilities in patients with Wilson's disease. Isaacs-Glaberman K, Medalia A, Scheinberg IH, Cortex 1989 25 3 353 361
76. Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20 days by BA 1, a N-(2-cyanoethylene)-urea. Novel prophylactic possibilities. Ardenne M, Reitnauer PG, Arzneimittelforschung 1975 25 9 1369 1379
77. Influence of a new virostatic compound on the induction of enzymes in rat liver. Kroger H, Donner I, Skiello G, Arzneimittelforschung 1975 25 9 1426 1429
78. Metal substitutions incarbonic anhydrase: a halide ion probe study. Smith RJ, Bryant RG, Biochem Biophys Res Commun 1975 66 4 1281 1286
79. Depression in hepatolenticular degeneration (Wilson's disease). Walter G, Lyndon B, Aust N Z J Psychiatry 1997 31 6 880 882
80. Mania as the first manifestation of Wilson's disease. Machado A, Deguti M, Caixeta L, Spitz M, Lucato L, Barbosa E, Bipolar Disord 2008 10 447 450
81. The inadvisability of neuroleptic medication in Wilson's disease. Tu J, Biol Psychiatry 1981 16 10 963 968
82. Hoogenraad T, Wilson's Disease London: Saunders 1996
83. Acute, progressive akinetic-rigid syndrome induced by neuroleptics in a case of Wilson's disease. Chroni E, Lekka NP, Tsibri E, Economou A, Paschalis C, J Neuropsychiatry Clin Neurosci 2001 13 4 531 532
84. Mania in a patient with Wilson's disease awaiting liver transplant. Varghese ST, Narayanan D, Dinesh D, J Neuropsychiatry Clin Neurosci 2008 20 4 501 502
85. [Psychiatric disorders treated with clozapine in a patient with Wilson's disease]. Krim E, Barroso B, Presse Med 2001 30 15 738
86. Quetiapine for mania with Wilson's disease. Kulaksizoglu IB, Polat A, Psychosomatics 2003 44 5 438 439
87. Treating mania in Wilson's disease with lithium. Longanathan S, Nayak R, Sinha S, Taly A, Math S, Varghese M, J Neuropsychiatry Clin Neurosci 2008 20 487 489
88. Successful ECT in a patient with a psychiatric presentation of Wilson's disease. Rodrigues AC, Dalgalarrondo P, Banzato CE, J ECT 2004 20 1 55
89. Wilson's disease, psychosis, and ECT. Shah N, Kumar D, Convuls Ther 1997 13 4 278 279
90. Results of ECT for a case of depression in Wilson disease. Negro P, Louza Neto M, J Neuropsychiatry Clin Neurosci 1995 7 384
91. Three sisters with very-late-onset major depression and parkinsonism. Sechi G, Antonio Cocco G, Errigo A, Deiana L, Rosati G, Agnetti V, Stephen Paulus K, Mario Pes G, Parkinsonism Relat Disord 2007 13 2 122 125
92. Wilson's disease with depression and parkinsonism. Chan K, Cheung R, Au-Yeung K, Mak W, Cheng T, Ho S, J Clin Neurosci 2004 12 303 305
93. Psychiatric symptoms as late onset of Wilson's disease: neuroradiological findings, clinical features and treatment. Keller R, Torta R, Lagget M, Crasto S, Bergamasco B, Ital J Neurol Sci 1999 20 49 54
94. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Moghadasian MH, Salen G, Frohlich JJ, Scudamore CH, Arch Neurol 2002 59 4 527 529
95. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Gallus GN, Dotti MT, Federico A, Neurol Sci 2006 27 2 143 149
96. Orphanet, Prevalence of Rare Diseases 2013 [cited 2014 January]; Available from: http://www.orpha.net/orphacom/cahiers/docs/FR/Prevalence-des- maladies-rares-par-prevalence-decroissante-ou-cas.pdf
97. Psychiatric disorders in patients with cerebrotendinous xanthomatosis. Berginer VM, Foster NL, Sadowsky M, Townsend JA 3rd, Siegel GJ, Salen G, Am J Psychiatry 1988 145 3 354 357
98. Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Barkhof F, Verrips A, Wesseling P, van Der Knaap MS, van Engelen BG, Gabreels FJ, Keyser A, Wevers RA, Valk J, Radiology 2000 217 3 869 876
99. Cholestanolosis (cerebrotendinous xanthomatosis). A follow-up study on the original family. Philippart M, Van Bogaert L, Arch Neurol 1969 21 6 603 610
100. Depression in a patient with dementia secondary to cerebrotendinous xanthomatosis. Shapiro S, J Nerv Ment Dis 1983 171 9 568 571
101. Case report 427: Cerebrotendinous xanthomatosis. Burnstein M, Buckwalter KA, Martel W, McClatchey KD, Quint D, Skelet Radiol 1987 16 4 346 349
102. Van Bogaert's cerebrotendinous xanthomatosis. A study of 3 cases. Laurent A, Dairou F, Luc G, Truffert J, Lapresle J, de Gennes JL, Ann Med Interne 1988 139 6 395 402
103. Paediatric cerebrotendinous xanthomatosis. Wevers RA, Cruysberg JR, Van Heijst AF, Janssen-Zijlstra FS, Renier WO, Van Engelen BG, Tolboom JJ, J Inherit Metab Dis 1992 15 3 374 376
104. The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature. Soffer D, Benharroch D, Berginer V, Acta Neuropathol 1995 90 2 213 220
105. Two new mutations in the sterol 27-hydroxylase gene in two families lead to cerebrotendinous xanthomatosis. Verrips A, Steenbergen-Spanjers GC, Luyten JA, van den Heuvel LP, Keyser A, Gabreels FJ, Wevers RA, Hum Genet 1996 98 6 735 737
106. Sudden death due to cerebrotendinous xanthomatosis confirmed by mutation analysis. Sperhake JP, Matschke J, Orth U, Gal A, Puschel K, Int J Legal Med 2000 113 2 110 113
107. Cerebrotendinous xanthomatosis: heterogeneity of clinical phenotype with evidence of previously undescribed ophthalmological findings. Dotti MT, Rufa A, Federico A, J Inherit Metab Dis 2001 24 7 696 706
108. Cerebrotendinous xanthomatosis with psychiatric disorders: report of three siblings and literature review. Lee Y, Lin PY, Chiu NM, Chang WN, Wen JK, Chang Gung Med J 2002 25 5 334 340
109. Unusual cerebrotendinous xanthomatosis with fronto-temporal dementia phenotype. Guyant-Marechal L, Verrips A, Girard C, Wevers RA, Zijlstra F, Sistermans E, Vera P, Campion D, Hannequin D, Am J Med Genet A 2005 139A 2 114 117
110. Cerebrotendinous xanthomatosis in a Saudi Arabian family-genotyping and long-term follow-up. Price Evans DA, Salah KA, Mobrad MA, Mitchell WD, Olin M, Eggertsen G, Saudi Med J 2007 28 7 1113 1118
111. Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress. Gonzalez-Cuyar LF, Hunter B, Harris PL, Perry G, Smith MA, Castellani RJ, Redox Rep 2007 12 3 119 124
112. Cerebrotendinous xanthomatosis presenting with severe externalized disorder: improvement after one year of treatment with chenodeoxycholic Acid. Bonnot O, Fraidakis MJ, Lucanto R, Chauvin D, Kelley N, Plaza M, Dubourg O, Lyon-Caen O, Sedel F, Cohen D, CNS Spectr 2010 15 4 231 236
113. Recommendations on the diagnosis and management of Niemann-Pick disease type C. Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, Mengel E, Pineda M, Sedel F, Topcu M, Vanier MT, Widner H, Wijburg FA, Patterson MC, Group N-CGW, Mol Genet Metab 2009 98 1-2 152 165
114. Niemann-Pick disease type C. Vanier MT, Orphanet J Rare Dis 2010 5 16
115. Recommendations for the diagnosis and management of Niemann-Pick disease type C: An update. Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F, on behalf of the NPCGWG, Mol Genet Metab 2012 106 3 330 344
116. Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Vanier MT, Neurochem Res 1999 24 4 481 489
117. The adult form of Niemann-Pick disease type C. Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, Sedel F, Brain 2007 130 Pt 1 120 133
118. Niemann-Pick type C disease in a 68-year-old patient. Trendelenburg G, Vanier MT, Maza S, Millat G, Bohner G, Munz DL, Zschenderlein R, J Neurol Neurosurg Psychiatry 2006 77 8 997 998
119. Natural history of Niemann-Pick disease type C in a multicentre observational retrospective cohort study. Wraith JE, Guffon N, Rohrbach M, Hwu WL, Korenke GC, Bembi B, Luzy C, Giorgino R, Sedel F, Mol Genet Metab 2009 98 3 250 254
120. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Porter FD, Scherrer DE, Lanier MH, Langmade SJ, Molugu V, Gale SE, Olzeski D, Sidhu R, Dietzen DJ, Fu R, Wassif CA, Yanjanin NM, Marso SP, House J, Vite C, Schaffer JE, Ory DS, Sci Transl Med 2010 2 56 56ra81
121. Therapy of Niemann-Pick disease, type C. Patterson MC, Platt F, Biochim Biophys Acta 2004 1685 1-3 77 82
122. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE, Lancet Neurol 2007 6 9 765 772
123. Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. Wraith JE, Vecchio D, Jacklin E, Abel L, Chadha-Boreham H, Luzy C, Giorgino R, Patterson MC, Mol Genet Metab 2010 99 4 351 357
124. Long-term miglustat therapy in children with Niemann-Pick disease type C. Patterson MC, Vecchio D, Jacklin E, Abel L, Chadha-Boreham H, Luzy C, Giorgino R, Wraith JE, J Child Neurol 2010 25 3 300 305
125. Case 1, 1995: psychosis, dementia, chorea, ataxia, and supranuclear gaze dysfunction. Shulman LM, Lang AE, Jankovic J, David NJ, Weiner WJ, Mov Disord 1995 10 3 257 262
126. Psychosis as a presentation of physical disease in adolescence: a case of Niemann-Pick disease, type C. Campo JV, Stowe R, Slomka G, Byler D, Gracious B, Dev Med Child Neurol 1998 40 2 126 129
127. [Presenting psychiatric and cognitive disorders in adult neurolipidoses]. Turpin JC, Baumann N, Rev Neurol 2003 159 6-7 Pt 1 637 647
128. Adult onset Niemann-Pick disease type C presenting with psychosis. Josephs KA, Van Gerpen MW, Van Gerpen JA, J Neurol Neurosurg Psychiatry 2003 74 4 528 529
129. [Presentation of Niemann-Pick type C disease with psychiatric disturbance in an adult]. Tyvaert L, Stojkovic T, Cuisset JM, Vanier MT, Turpin JC, De Seze J, Vermersch P, Rev Neurol 2005 161 3 318 322
130. The neuropsychiatry of Niemann-Pick type C disease in adulthood. Walterfang M, Fietz M, Fahey M, Sullivan D, Leane P, Lubman DI, Velakoulis D, J Neuropsychiatry Clin Neurosci 2006 18 2 158 170
131. Gender dimorphism in siblings with schizophrenia-like psychosis due to Niemann-Pick disease type C. Walterfang M, Fietz M, Abel L, Bowman E, Mocellin R, Velakoulis D, J Inherit Metab Dis 2009 Sup1 221 226
132. Niemann-Pick disease type C1 presenting with psychosis in an adolescent male. Sandu S, Jackowski-Dohrmann S, Ladner A, Haberhausen M, Bachmann C, Eur Child Adolesc Psychiatry 2009 18 9 583 585
133. Post-ictal psychosis in adolescent Niemann-Pick disease type C. Walterfang M, Kornberg A, Adams S, Fietz M, Velakoulis D, J Inherit Metab Dis 2010 13 Sup3 63 65
134. Treatable metabolic psychosis that go undetecd: What Niemann Pick type C can teach us. Klunemann HH, Santosh PJ, Sedel F, Int J Psychiatry Clin Pract 2012 16 3 1 8
135. Clinical features of Niemann-Pick disease type C. An example of the delayed onset, slowly progressive phenotype and an overview of recent literature. van de Vlasakker CJ, Gabreels FJ, Wijburg HC, Wevers RA, Clin Neurol Neurosurg 1994 96 2 119 123
136. Neuropsychological profile of adult patients with Niemann-Pick C1 (NPC1) mutations. Klarner B, Klunemann HH, Lurding R, Aslanidis C, Rupprecht R, J Inherit Metab Dis 2007 30 1 60 67
137. Therapies for inborn errors of metabolism: what has the orphan drug act delivered? Talele SS, Xu K, Pariser AR, Braun MM, Farag-El-Massah S, Phillips MI, Thompson BH, Cote TR, Pediatrics 2010 126 1 101 106
138. The evolving concept of schizophrenia: from Kraepelin to the present and future. Andreasen NC, Schiz Res 1997 28 2-3 105 109
139. Neighbourhood variation in incidence of schizophrenia. Evidence for person-environment interaction. van Os J, Driessen G, Gunther N, Delespaul P, Br J Psychiatry 2000 176 243 258
140. The Environment and Disease: Association or Causation? Hill AB, Proc R Soc Med 1965 58 295 300
141. From neuropathology to neurodevelopment. Weinberger DR, Lancet 1995 346 8974 552 557
142. Light-induced changes of absorbance and electron spin resonance in small photosystem II particles. Van Gorkom HJ, Pulles MP, Wessels JS, Biochim Biophys Acta 1975 408 3 331 339
143. Schizophrenia. van Os J, Kapur S, Lancet 2009 374 9690 635 645
144. The phenomenology of acute organic psychosis. Comparison with acute schizophrenia. Cutting J, Br J Psychiatry 1987 151 324 332
145. Pathogenesis and symptomatology of hallucinations (delusions) of organic brain disorder and schizophrenia. Horiguchi J, Miyaoka T, Shinno H, Psychogeriatrics 2009 9 2 73 76
146. Very late-onset schizophrenia-like psychosis: clinical and imaging characteristics in comparison with elderly patients with schizophrenia. Barak Y, Aizenberg D, Mirecki I, Mazeh D, Achiron A, J Nerv Ment Dis 2002 190 11 733 736
147. Visual hallucinations: differential diagnosis and treatment. Teeple RC, Caplan JP, Stern TA, Prim Care Companion J Clin Psychiatry 2009 11 1 26 32
148. Association of adolescent catatonia with increased mortality and morbidity: evidence from a prospective follow-up study. Cornic F, Consoli A, Tanguy ML, Bonnot O, Perisse D, Tordjman S, Laurent C, Cohen D, Schizophr Res 2009 113 2-3 233 240
149. Early-onset schizophrenia. Remschmidt H, Theisen F, Neuropsychobiology 2012 66 1 63 69
150. The neuropsychiatry of inborn errors of metabolism. Walterfang M, Bonnot O, Mocellin R, Velakoulis D, J Inherit Metab Dis 2013 36 4 687 702
151. The costs of schizophrenia. McEvoy JP, J Clin Psychiatry 2007 68 Suppl 14 4 7